We are exhibiting at the SCI’s New Modalities: Innovations in Peptides as Biotherapeutics event on 25 April 2024 in London. Please drop by the stand to find out more about Charnwood Discovery’s peptide capabilities.
Innovations in Peptides as Biotherapeutics
Peptides as a drug modality offer several advantages over both traditional small molecules and biologics. These include improved tissue penetration, simpler and more modular design characteristics. Peptides can also access previously intractable targets, as well as reduced immunogenic risks.
The advancement of peptides as therapeutics has been aided by the development of peptide drug conjugates. The SCI’s New Modalities: Innovations in Peptides as Biotheraputics event brings together world-class and cutting-edge scientists in the fields of peptide and peptide macrocyclic drug and drug conjugate research.
This event gives insights into the challenges posed and also the potential for these drugs to make a real-world impact, while allowing attendees to interact with active researchers.
Senior Business Development Manager, Dr Linos Lazarides is in London on Thursday 25 April 2024.
He will be availiable to answer questions about how Charnwood Discovery’s peptide capabilities can support any of your peptide programs.
If you would like to arrange a meeting with Linos please click the button below. Alternatively you can connect directly with Linos on LinkedIn.
Register for New Modalities: Innovations in Peptides as Biotherapeutics
If you would like to learn more about the event and how to register please follow the link below:
Charwood Discovery's Peptide Capabilities
Our peptide chemists will work with you from start to finish to ensure you maximize the output of your peptide project.
Utilizing their expertise, our seasoned peptide chemists design the most efficient route for your peptide. They also select the optimal resin to meet your goals.
- Off resin modifications
- Peptide cyclization
- SPPS with unnatural amino acids
Find out more from our FAQs: